ModernMedicine Featured CME: Primary Care
Having trouble viewing this e-mail? Click here
You are subscribed as %%EMAIL_ADDRESS%%
To unsubscribe, click here
 
ModernMedicine
Featured CME: Primary Care
 
CME is free for registered members. Not a member?
Click here or on any link below to join the ModernMedicine Network today.
 
Alzheimer's Disease in Primary Care: Screening and Assessment Tools
Poor identification and recognition of Alzheimer's disease (AD) can have profound consequences for both the patient and their caregiver. A delay in diagnosis postpones patient care and treatment allowing for disease progression, putting the patient at risk, and increasing caregiver burden.
Primary care physicians (PCPs) are insufficiently educated on geriatric neurological disorders (eg AD) and as such inherently fail to appreciate the burden of AD, leading to the mistaken belief that there is little value in the diagnosis of AD. This ultimately results in a significant delay in diagnosis and treatment, diminished patient quality of life, and increased risk of caregiver burden, health crisis, and institutionalization.
Furthermore, PCPs may inadequately identify early signs of AD from other types of dementia syndromes, as they may be unaware of distinguishing clinical characteristics and innovative neuroimaging tools. This may lead to misdiagnosis, suboptimal patient care, and potentially incorrect treatment plans.
In addition, PCPs may be inadequately educated on the most recent AD clinical trial results, and may lack the knowledge and confidence in applying these findings to their patients with AD. Therefore, early-stage AD patients may not receive the highest standard of care, putting them at risk for health crises including falls, use of physical or chemical restraints, and institutionalization.
Upon completion, participants should be able to identify the continuum and progressive disease burden associated with Alzheimer's disease (AD); use methods to assess cognitive function that are appropriate in primary care practice and can aid in a timely and accurate diagnosis of AD; define the potential benefits of initiating pharmacotherapy as early as possible in patients with AD. » Go to this activity
 
 
 
Click here to see all
Primary Care CME programs
 
 
 

You are subscribed to ModernMedicine.com. To unsubscribe, click here

To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.